REFERENCES
- Haram K, Svendsen E, Abilgaard U. The HELLP syndrome: clinical issues and man-agement. A review. BMC Pregnancy and Childbirth 2009; 9(8): 1–15.
- Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in under-standing of pathogenesis of aHUS and HELLP. BJH 2008; 143: 336–348.
- Mihu D, Costin N, Mihaela Mihu C, Seicean A, Ciortea R. HELLP syndrome — a mul-tisystemic disorder. J Gastrointestin Liver Dis 2007; 16(4): 419–424.
- Lynch AM, Murphy JR, Byers T et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obst Gyn 2008; 198: 385 el-e9.
- Girard G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Journal of Experimental Medicine 2006; 203: 2165–2175.